Current Edition

cancer

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, the world’s largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approach to driving …

Continue Reading →
buyout

Novartis ups investment in gene therapy for the eye with $800M buyout

Novartis’ offer comes three months after Gyroscope presented at a medical meeting early data from 13 patients who had been dosed with the gene therapy, …

Continue Reading →
Antibody

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, …

Continue Reading →
$2.2M

Aptamer Group: UK Biotech Business Raises $2.2M Investment

Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors …

Continue Reading →
Biotech

Pfizer Expands Investment in Biotech through Pfizer Ventures

Company will spend $600 million on emerging/growth enterprises, with a focus on neuroscience. Pfizer Ventures, the venture capital arm of Pfizer, Inc, was founded in …

Continue Reading →
biopharma

Chinese biopharma firm to create 400 jobs in Dundalk

WuXi Biologics will invest €325m in company’s first site outside of China A major Chinese biopharmaceutical company is to create 400 jobs with a €325 …

Continue Reading →
ADC Bio

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in …

Continue Reading →